Multi-channel multi-distance broadband nearinfrared spectroscopy system to measure the spatial response of cellular oxygen metabolism and tissue oxygenation by Phan, PT et al.
Multi-channel multi-distance broadband near-
infrared spectroscopy system to measure the 
spatial response of cellular oxygen 
metabolism and tissue oxygenation 
PHONG PHAN,1,* DAVID HIGHTON,2 JONATHAN LAI,1 MARTIN SMITH,1,2 
CLARE ELWELL,1 AND ILIAS TACHTSIDIS1 
1Department of Medical Physics and Biomedical Engineering, UCL, London WC1E 6BT, UK 
2Neurocritical Care Unit, The National Hospital for Neurology and Neurosurgery, University College 
London Hospitals, Queen Square, London WC1N 3BG, UK 
*thanh.phan.11@ucl.ac.uk 
Abstract: We present a multi-channel, multi-distance broadband near-infrared spectroscopy 
(NIRS) system with the capability of measuring changes in haemoglobin concentrations 
(Δ[HbO2], Δ[HHb]), oxidation state of cytochrome-c-oxidase (Δ[oxCCO]) and tissue oxygen 
saturation (TOI) in the adult human brain. The main components of the instrument are two 
customized spectrographs and two light sources. Each spectrograph is lens-based to improve 
light throughput, has a grating enhanced to optimise reflection in the near-infrared (NIR) 
spectral region and uses a front illuminated cooled CCD camera (−70° C) with a square chip 
dimension of 12.3 x 12.3 mm (512 x 512 pixels). Each light source uses a 50W halogen bulb 
with a gold plated mirror to increase the intensity of the NIR light. Each light source was 
connected to a custom-built bifurcated fibre bundle to create two source fibre bundles (3.2 
mm diameter each). Each spectrograph received light input from another custom-built fibre 
bundle comprised of six individual bundles (one with 0.6 mm diameter and the other five 
with 1.5 mm diameter). All fibre bundles were fixed on a 3D printed optode holder (two light 
sources x two fibre bundles each = four probes; and two spectrographs x six fibre bundles 
each = 12 probes) that allowed 24 multi-distance channels across the forehead (six channels 
at 20 mm, three channels at 30 mm and 15 channels at 35 mm) and six TOI measurements. 
We demonstrated the use of the system in a cohort of nine healthy adult volunteers during 
prefrontal cortex functional activation using the Stroop task. We have observed functional 
responses identified as significant increase in Δ[HbO2], decrease in Δ[HHb] and increase in Δ[oxCCO] in five channels (out of 12), that overlay the left and right dorsolateral prefrontal 
cortices. There was no observable TOI functional response and we have shown small 
variations in TOI across different sites within the same subject and within the same site 
across subjects. 
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1. Introduction 
Near-infrared spectroscopy (NIRS) has for many years been used to investigate changes in 
haemodynamics and metabolism of various types of biological tissue, including the adult 
human brain [1–3]. To date, most commercial continuous wave (CW) functional NIRS 
(fNIRS) devices rely on dual wavelength approaches, limiting their capabilities to the 
measurements of concentration changes of oxygenated (Δ[HbO2]) and deoxygenated 
haemoglobins (Δ[HHb]) [4]. These measurements are not directly related to changes in 
metabolic activity during neuronal activation. An independent metabolic signal that is a 
direct marker of cellular oxygen metabolism may provide a platform to study the relationship 
between vascular haemodynamics and neuronal metabolism, as well as the balance between 
brain tissue oxygenation and utilisation in different scenarios. The broadband NIRS 
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measurement of oxidised cytochrome-c-oxidase (Δ[oxCCO]) has great potential to be this 
candidate. 
Cytochrome-c-oxidase (CCO) is the terminal enzyme in the mitochondrial electron 
transport chain, responsible for more than 95% of cellular oxygen metabolism for the 
synthesis of adenosine triphosphate. Measurement of the changes in the oxidation state of 
CCO can be used as a biomarker for cellular oxygen metabolism [5,6]. The difference in the 
absorption spectrum between the oxidised and the reduced species of CCO has distinct 
characteristics in the near-infrared region (NIR) (780 - 900 nm) with a broad peak at 830 nm 
and this can be used to resolve Δ[oxCCO]. Previously, we have extensively described an 
optimized NIRS approach for the detection of Δ[oxCCO] using broadband spectroscopy (780 
– 900nm) [7]. This approach addresses specific challenges of detecting this chromophore: 1) 
its concentration is less than 10% of haemoglobin concentration and 2) risk of crosstalk 
artefact between chromophores with overlapping spectra [8–10]. A recent review by Bale and 
colleagues provides details on the spectral features of CCO, the methodology, analysis 
techniques as well as a summary of human brain studies regarding the NIRS measurement of 
cerebral oxCCO in both the healthy and injured brain [11]. 
Beyond the measurement of ∆[HbO2], ∆[HHb] and ∆[oxCCO], a more complex NIRS 
technique called spatially resolved spectroscopy (SRS) can be implemented to monitor the 
absolute level of oxygenation in tissue. SRS is an established technique using multiple 
source-detector distances to calculate the tissue oxygenation index (TOI), the ratio of 
oxygenated to total tissue haemoglobin, which can be used as a marker of the balance 
between tissue oxygen supply and demand [12,13]. This index has found initial success as a 
cerebral oxygenation monitor to guide haemodynamic and oxygenation management during 
cardiac surgery [14,15]. There is potential benefit in combining the measurements of 
∆[HbO2], ∆[HHb] and ∆[oxCCO] with TOI to investigate the balance between cerebral 
oxygen delivery and utilisation in multiple clinical scenarios. 
Investigations of the localisation of functional brain activity require recording of changes 
from multiple brain regions. In addition, certain brain injuries affect localised areas of the 
brain and it is of clinical importance to identify and monitor changes in those regions of 
interest. Moreover, previous investigation of Δ[oxCCO] using a dual channel system during 
functional activation by Kolyva et al. [16] suggested regional heterogeneity in the oxCCO 
response and this requires further investigation. However, to date, most systems that have the 
capability to measure changes in oxCCO signal and TOI have a limited number of channels, 
restricting measurements to only one or two locations. Table 1 provides a brief summary of 
broadband NIRS systems with capability of measuring the ∆[oxCCO]. There is an unmet 
need to deliver a multi-channel broadband NIRS system to monitor ∆[oxCCO] and TOI. 
Table 1. Brief summary of NIRS oxCCO measurement systems 
NIRS systems Number of wavelengths 
Number of 
source(s) 
Number of 
detector(s) 
Number of 
simultaneous 
channels used 
Multi-distance/ TOI 
Duke 1 [17,18] 3 1 1 1 No/No 
Duke 2 [19] 4 1 1 1 No/No 
UCL 1 [20] 4 1 1 1 No/No 
Keele 1 [21] 3 1 1 1 No/No 
Keele 2 [22] 4 1 1 1 No/No 
NIRO 1000 [23], 6 1 1 1 No/No 
NIRO 500 [24] 4 1 1 1 No/No 
NIRO 300 [13,25] 4 1 3 1 Yes/Yes 
UCLn [26–28] Broadband 1 1 1 No/No 
UCLn–CYRIL [29] Broadband 2 8 2 Yes/Yes 
UCL Hybrid [30] Broadband 2 8 2 Yes/Yes 
Humboldt 1 [31] Broadband 1 1 1 No/No 
Humboldt 2 [10] Broadband 1 4 4 No/No 
Ryerson 1 [32] Broadband 2 2 2 No/No 
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The aim of this paper is to present a broadband NIRS system with the capability of 
measuring not only the haemodynamic changes, but also the oxCCO response, and TOI using 
24 multi-distance channels across the prefrontal cortex of the adult brain. To demonstrate the 
capability of the system, we used it to monitor the prefrontal cortex during functional 
activation induced by the Stroop task; and we investigate the functional response of the 
oxCCO signal by identifying channels with significant change during the functional task. 
TOI values were recorded to demonstrate the capability of the system to monitor variations in 
oxygenation across multiple regions. 
2. Methods 
2.1 Instrumentation 
Figure 1(a) shows the schematic of the multi-channel, multi-distance broadband NIRS 
system. It employs two light sources each with a gold plated mirror and a 50W halogen bulb 
(Phillips) with an axial filament to emit a broadband NIR enhanced spectrum. The output 
spectrum is filtered to remove wavelengths below 504 nm and above 1068 nm to reduce UV 
exposure and heating effects. The optical intensity delivered to the tissue was 130 mW/cm2, 
which is within tissue safety limits for incoherent source of 200 mW/cm2 [33]. Each of the 
two light sources has a solenoid shutter (Melles Griot, USA) that is controlled by an 
electronic shutter controller (Melles Griot, USA). Light from each source is directed to the 
subject via a custom-built bifurcated optical fibre bundle (Fig. 1(b)) (individual glass fibres 
having diameter of 70 µm, NA= 0.57, Loptek Glasfasertechnik GmbH, Germany). The 
bundle diameter at the light source end is 4.5 mm, which then splits into two individual fibre 
bundles with 3.2mm diameter each (Fig. 1(b) and 1(c)) at the subject end. This effectively 
creates two pairs of source fibre bundles (Fig. 1(c)). A time multiplexing mechanism is used 
to control the open and close of the shutters of the light sources (Fig. 1(a)) hence allowing 
one light source to be on every 1.4 s, delivering light to the pair of source fibre bundles 
connected to it. As a result, a single complete acquisition cycle takes 2.8 s (or 0.35 Hz) and 
this allows data from all 24 measurement channels to be acquired. 
To collect, separate and measure the intensity of light from the tissue at each wavelength, 
the system has two custom built spectrographs, each of which is connected to a front 
illuminated CCD camera (PIXIS: 512f, Princeton Instruments). The spectrograph is lens-
based rather than mirror-based to provide higher light-throughput. The spectrograph contains 
Minolta MC Rokkor lenses with the focal length of f = 58 mm and an f-number of f/# = 
1:1.2. The grating of the spectrograph (GR50-0310, Thorlabs) has dimensions of 50 x 50 x 
9.5 mm with 300 grooves per mm blazed at 1000 nm to optimise reflection in the NIR region. 
The light spectrum is detected by two CCD cameras (PIXIS: 512f, Princeton Instruments) 
each with chip dimension of 12.3 x 12.3 mm corresponding to 512 x 512 pixels with a pixel 
size of 24 x 24 μm. The CCD cameras are cooled to −70 °C to reduce thermal noise and 
increase sensitivity. Each spectrograph is connected to a 3 m long detector fibre bundle 
(individual glass fibres having a diameter of 70 µm, NA = 0.54, Loptek Glasfasertechnik 
GmbH, Germany) (Fig. 1(d)), which at the subject end branches into six individual fibre 
bundles (Fig. 1(e)), five with bundle diameter of 1.5 mm and one with bundle diameter of 0.6 
mm. Overall, at the subject end, the system has four source fibre bundles and 12 detector 
fibre bundles resulting in a total of 24 measurement channels. 
                                                                             Vol. 7, No. 11 | 1 Nov 2016 | BIOMEDICAL OPTICS EXPRESS 4428 
 Fig. 1. (a) Schematic showing all the components of the system. The system has two light 
sources, each has a solenoid shutter that is controlled by an electronic shutter controller with a 
time multiplexing mechanism. Light from the sources (filtered to 504nm – 1068nm) is 
directed to the subject by means of bifurcated optical fibre bundles, creating four source fibre 
bundles at the subject end. The diffused light from the subject head is collected using 12 
detector fibre bundles branched from two fibre bundles, each of the two is connected to a 
spectrograph and a CCD camera. Both spectrographs are controlled by another electronic 
shutter controller. The system is run by LabVIEW software from a computer. (b) The common 
ends (attached to the light sources) of two bifurcated source fibre bundles. Bifurcation creates 
four individual source fibre bundles (c) at the subject end from two common bundles. (d) The 
detector fibre bundles at the spectrograph end. (e) The twelve individual detector fibre bundles 
which are branched from (d) and are attached to the subject. 
Figure 2 shows the interface between the system and the subject. The optical interface 
between the optical fibre bundles and the subject is provided by an optode holder (Fig. 2(a)) 
that was designed specifically for the application on the adult forehead, enabling multi-
channel NIRS measurements simultaneously. The holder was designed using AutoCad 
(AutoDesk) software to accommodate the dimensions of the fibre bundle heads and to ensure 
enough friction to hold the bundle heads in place during application (Fig. 2(b)). The holder 
was 3D printed with a combination of hard (Vero White) and flexible (Tango Black) 
materials to accommodate the curvature of the adult human forehead. Figure 2(c) 
demonstrates the operation of the system with the time multiplexing mechanism, switching 
light to the paired sources every 1.4 s. Figure 2(d) demonstrates the application of the system 
on a subject’s forehead. 
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 Fig. 2. The interface between the system and the subject. (a) 3D printed optode holder. (b) 
Four source fibre bundles and 12 detector fibre bundles fixed on the optode holder on a solid 
phantom. (c) Illustration showing one complete acquisition cycle during which each of the two 
pairs of the source fibre bundles delivers light one after the other. (d) The optode holder with 
fibre bundles is fixed on a subject forehead using a headband. 
The optode holder design has four source locations (numbered 1 to 4), with inter-source 
distance of 45 mm, and detector locations arranged to enable 24 broadband NIRS 
measurement channels and six TOI measurements using 12 detector fibre bundles (numbered 
1 to 12) (Fig. 3(a)). Four source fibre bundles and 12 detector fibre bundles were placed in 
the optode holder, as shown in Fig. 3(a), so that two 0.6 mm diameter detector fibre bundles 
occupy location 1 and 12 and the other locations were filled with 1.5 mm diameter detector 
fibre bundles. Detector fibre bundles from location 1 to 6 were from one common bundle 
connected to the first spectrograph, and detector fibre bundles from location 7 to 12 were 
from the other common bundle connected to the second spectrograph. The source-detector 
separations (SDS) of the 24 channels range from 20 mm to 35 mm. During operation, source 
fibre bundles are fixed in the holder such that the two source fibre bundles that are operating 
simultaneously have a separation of 90 mm (as demonstrated in Fig. 2(c)) ensuring that 
detector fibre bundles only receive light from one source fibre bundle at a time. Figure 3(b) 
shows measurement channels that are acquiring data when the paired sources are on, and Fig. 
3(c) shows the spatial locations of all 24 possible measurement channels. Figure 3(d) shows 
the locations of detector fibre bundles that are used for the calculation of TOI that will be 
discussed in more detail in algorithm section. The optode holder is fixed on the subject’s 
forehead using double-sided medical tape laser-cut in the shape of the optode holder to 
reduce movement artefacts. Overall, the system has the capability of acquiring data from 24-
channel NIRS measurements of changes in [HbO2], [HHb] and [oxCCO] and measurement of 
TOI from six regions of the forehead. 
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 Fig. 3. (a) Probe design showing the locations of four source fibre bundles numbered from 1 to 
4 (red circles) and 12 detector fibre bundles numbered from 1 to 12 (cyan circles).The distance 
between neighbor source bundles is 45 mm and the SDS ranges from 20 mm to ~35 mm*. (b) 
Measurement channels acquired when alternative paired source bundles are on. Red circles 
indicate the locations of the working source bundles and cyan circles indicate the locations of 
the detector bundles. Dark green, magenta and light blue arrows indicate channels with SDS 
of 35 mm, 30 mm and 20 mm respectively. (c) The spatial distribution of all 24 measurement 
channels. Colour coding for SDS is similar to b. Circle size is proportional to SDS. (d) 
Detector bundles used for each TOI calculation. TOI 1 uses detector bundles 2 and 3, TOI 2 
uses detector bundles 3 and 4, TOI 3 uses detector bundles 5 and 6, TOI 4 uses detector 
bundles 7 and 8, TOI 5 uses detector bundles 9 and 10 and TOI 6 uses detector bundles 10 and 
11. *The absolute geometrical distances between source and detector ranges from 20mm to 
35.6mm; however due to uncertainties introduced by the forehead curvature the actual source 
detector distance is most likely to be slightly different to the geometrical one. 
A LabVIEW program (National Instruments) was used to integrate light source switching 
with optical intensity measurement of the CCD cameras. The program removes the 
background thermal noise before combining intensity measurements of light from the 
detector bundle projected over different binned regions of the CCD camera. All data from 
every individual detector bundles connected to one spectrograph are captured at the same 
time. The intensity spectra from 504 to 1068 nm were projected over the CCD x axis and 
individual detector bundles were separated in the CCD y axis. To normalize the intensity 
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spectrum measured by different detector bundles, gain factors for each of them were 
estimated. Reference intensity spectra from every detector bundles when they were exposed 
to the same amount of light input from an integrating sphere were recorded. Gain factors 
were then calculated by dividing the intensity spectrum of each of the 1.5 mm diameter 
bundles to the intensity spectrum of the 0.6 mm diameter bundle. 
2.2 Algorithms 
The UCLn algorithm (1) was used to convert the attenuation change measured across 108 
wavelengths (from 780nm to 900nm) to concentration changes of chromophores applying the 
Modified Beer-Lambert Law (MBLL) [10, 30]. UCLn algorithm is a least-squares fitting 
procedure, finding the best fit of chromophore concentration changes based on the 
chromophores’ extinction coefficients and the measured attenuation changes over n number 
of wavelengths. A large number of wavelengths was used, as suggested by Matcher and 
colleagues [10], to resolve ∆[oxCCO] because calculating ∆[oxCCO] from a small number of 
wavelengths can give spurious changes. 
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The differential attenuation (ΔA) is calculated from measurements of the intensity 
spectrum. The optical pathlength used for the UCLn algorithm is the product between the 
source-detector separation and the differential pathlength factor (DPF). The DPF at 807nm 
was assumed to be 6.26 for all detectors [34]. The value of DPF for other wavelengths from 
780 to 900 nm was calculated by taking into account the wavelength dependence of the DPF 
as DPF falls with increasing wavelength [16, 35]. 
TOI was calculated using the principle of SRS [12], an established technique based on 
measuring light attenuation at several different SDSs. Detailed description of the technique 
has been described elsewhere [12, 30]. Briefly, the attenuation slope (∂A/ ∂ρ) was calculated 
using the intensity measurements from two detectors at different distances for each 
wavelength from 740-900 nm. The result was used to calculate the scaled absorption 
coefficient spectrum kμa (k is an unknown constant), taking into account the wavelength 
dependency of scattering by applying a correcting factor (1-hλ) where h = 0.00085 mm−1nm−1 
[36]. The kμa was then used to calculate the scaled absolute concentrations of HbO2 
(k[HbO2]), HHb (k[HHb]) and water (k[H2O]). The scaled concentrations were used to 
calculate TOI, the ratio between k[HbO2] and scaled total haemoglobin k([HbO2] + [HHb]). 
2.3 Study protocol and data analysis 
2.3.1 Stability and noise characterisation 
In order to investigate the thermal noise and dark count of the CCD cameras, data were 
acquired from all 12 detector fibre bundles for 20 minutes with the shutter of the 
spectrograph closed. Intensity distribution across 108 wavelengths and the change in intensity 
of individual wavelength along time were investigated. 
2.3.2 Source interference 
Given that the system utilises two light source bundles at the same time there is a risk that 
one detector bundle will receive light from both of the source bundles. To characterise this 
possible interference, two experiments were performed, one of which was on a homogeneous 
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phantom with tissue-like optical properties and the other on a healthy adult volunteer 
forehead. The optode holder was fixed on the phantom or the forehead using double-sided 
tape and 12 detector fibre bundles were positioned on the holder as described in Fig. 3(a) to 
collect the intensity data. One source fibre bundle was translated consecutively from source 
locations 1 to 4. To represent the intensity measured by each detector bundle, mean intensity 
across 108 wavelengths from 780 to 900 nm was calculated for all 12 detector bundles for 
both experiments. Using data from individual source illumination, SNR was calculated for 24 
channels to assess and quantify the effect of double illumination. SNR is defined as the ratio 
of intensity count used for the measurements and the intensity due to noise. The SNRs when 
sources 1 and 3 were on and when sources 2 and 4 were on were calculated. 
2.3.3 Frontal lobe functional activation 
Following ethics approval and volunteer consent, a pilot study was conducted in nine healthy 
adult volunteers with the probe holder positioned across the midline of the forehead such that 
source locations 2 and 3 were located at Fp2 and Fp1 according to 10/20 EEG electrode 
placing system [37]. Prefrontal lobe activation was achieved with a modified version of the 
Stroop task [38]. The block design consisted of 10 epochs, each with a 30 s black screen 
followed by a 60 s Stroop task and then a 30 s black screen. Total acquisition time was 1200 
s. During the 60 s Stroop task, subjects were presented with a series of coloured words 
written in coloured ink and asked to name the colour of the individual word while ignoring its 
meaning. Four colour options were used: red, green, blue and magenta. The stimulation was 
presented to the subject using a 17-inch laptop computer positioned 40 cm away from the 
subject and the subject responded by pressing the corresponding keys. Attenuation changes 
were acquired by 12 detector fibre bundles continuously while the light from the paired 
source fibre bundles was switching. Time course concentration changes of the three 
chromophores (∆[HbO2], ∆[HHb] and ∆[oxCCO]) were calculated from the acquired 
attenuation changes using the UCLn algorithm as described previously. Concentration 
changes were filtered using a 5th order Butterworth low pass filter with cut-off frequency of 
0.0875 Hz, linearly detrended and then resampled to 1 Hz. For each subject, concentration 
changes were block-averaged across each epoch to produce three 120s traces (∆[HbO2], 
∆[HHb] and ∆[oxCCO]) for each measurement channel. The mean concentration changes in 
individual channels were then averaged across nine subjects to produce the grand average 
activation map across the frontal lobe for the Stroop task. In this study, cortical activation is 
defined by an increase in Δ[HbO2], decrease in Δ[HHb] and increase in Δ[oxCCO]. To 
identify channels with significant changes due to functional stimulation, the response of each 
channel for each subject was defined as the difference between the mean of the first 10s 
window of activation and the mean of the first 10s window during the black screen period. 
Paired t-tests were used to compare the responses of each channel across all nine subjects to 
zero (i.e no response). p < 0.05 was considered statistically significant. This was done for 
each of the three chromophores. 
2.3.4 Tissue oxygen saturation 
TOI values were calculated as described earlier for six sites of measurements indicated in 
Fig. 3(d) as TOI 1 to TOI 6. Using the slope of the attenuation between the closest detector 
(20 mm SDS) and the furthest detector (35 mm SDS) for sites 2, 3 and 5, between the 30 mm 
and the 35 mm detectors for sites 1 and 6, and between the 20 mm and the 30 mm detectors 
for site 4, scaled absorption coefficients (kμa) were calculated and then used to estimate 
scaled absolute concentrations of HbO2 and HHb (k[HbO2] and k[HHb]) for each site. These 
values were then used to calculate TOI for different sites [30]. To investigate the spatial 
variations in TOI in different regions, mean TOI was calculated by taking the average of TOI 
values across the whole experiment period for each of the six sites. 
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2.3.5 Systemic data analysis 
Systemic physiological monitoring data were collected simultaneously with NIRS 
measurements. Arterial blood pressure (ABP) was measured with a Portapres® system 
(Finapres Medical Systems, the Netherlands); scalp blood flow was measured by Laser 
Doppler Monitor (Moor Instruments); and end-tidal carbon dioxide (EtCO2), arterial oxygen 
saturation and heart rate were measured with a clinical monitor IntelliVue (Philips, the 
Netherlands). Systemic changes were block-averaged according to epoch and averaged 
across nine subjects. For each systemic variable, the response for each subject was defined as 
the difference between the mean of the first 10s window of activation and the mean of the 
first 10s window during the black screen period. Paired t-tests were used to compare the 
responses across nine subjects to zero, identical to the statistical analysis done for the NIRS 
signals. 
3. Results 
3.1 System stability and noise characterisation 
The intensity measurement across 108 wavelengths (from 780nm to 900nm) of one detector 
fibre bundle is presented in Fig. 4(a). The distribution has a flat shape with no prominent 
features and low intensity value as expected when there is no light input into the 
spectrograph. Figure 4(b) shows the intensity change at one wavelength over time (λ = 
780nm). The intensity change has a mean value of 5 ± 3 counts. 
 
Fig. 4. (a) The intensity spectrum measured by one detector fibre bundle when the shutter to 
the spectrograph is closed. (b) The intensity change at wavelength 780 nm over time during 
the test. 
3.2 Source interference and channel selection for analysis 
Table 2 and Table 3 present the intensity values collected by 12 detector fibre bundles 
(numbered according to Fig. 3(a)) on the homogeneous phantom and on the adult forehead 
respectively. These are intensity values when only one light source fibre bundle was used at 
location 1 to 4 successively. The shaded grey values on each column are from detector fibre 
bundles that are used for measurement channels for each of the light source bundle as 
indicated by Fig. 3(b). The non-shaded counts are from the detector bundles that are not used 
for measurement channels. 1 and 3 SNR was calculated by dividing the intensity values from 
the shaded column to the non-shaded one using column 1 and 3 only. Similar calculations 
were used for 2 and 4 SNR. There are two cases where SNRs are small (<5) (indicated by 
bold numbers in Table 2 and 3) in both the phantom and adult head. The first happens 
between source 3 and detector bundle 5, corresponding to channel 24 and the second happens 
between source 4 and detector bundle 12, corresponding to channel 19. Those two channels 
are excluded from further analysis. 
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Table 2. Intensity counts from 12 detector fibre bundles with individual sources on the 
phantom. 
Detector 
number 
Source 1 Source 2 Source 3 Source 4 1 and 3 SNR 2 and 4 SNR 
1 776 963 16 9 48.50 107.00 
2 2793 4240 32 8 87.28 530.00 
3 1032 4650 43 8 24.00 581.25 
4 144 13150 15 8 9.60 1643.75 
5 21 10858 58 8 2.76 1357.25 
6 103 4841 784 10 7.61 484.10 
7 8 2640 4879 182 609.88 14.51 
8 4 162 4693 20 1173.25 8.10 
9 4 21 6482 227 1620.50 10.81 
10 7 129 1910 1991 272.86 15.43 
11 6 8 1759 4499 293.17 45.91 
12 6 30 361 119 60.17 3.97 
Table 3. Intensity counts from 12 detector fibre bundles with individual source on an 
adult forehead 
Detector 
number 
Source 1 Source 2 Source 3 Source 4 1 and 3 
SNR 
2 and 4 SNR 
1 490 505 7 5 70.00 101.00 
2 2506 2402 12 4 208.83 600.50 
3 956 2543 16 5 59.75 508.60 
4 120 8655 5 4 24.00 2163.75 
5 9 4636 32 4 3.56 1159.00 
6 57 2584 421 6 7.39 430.67 
7 7 1621 2737 76 391.00 21.33 
8 4 98 2601 8 650.25 12.25 
9 5 8 3210 143 642.00 17.88 
10 5 53 1018 1279 203.60 24.13 
11 4 42 948 3098 237.00 73.76 
12 5 14 175 45 35.00 3.21 
3.3 Functional activation 
Based on the values of the intensity collected from different channels using the experimental 
system described in the Methods section, channels 1, 4 and 22 (Fig. 3(c)) are excluded from 
analysis due to low intensity. Figure 5(a) presents the positions of 19 channels on the 
forehead. Figure 5(b) presents group block-averaged concentration changes and standard 
error of mean of the three chromophores during the Stroop task across nine subjects with 
different SDS indicated by the borders of the plots. The concentration change of oxCCO is 
multiplied by 10 for ease of visualisation. There is a spatial variation of the oxCCO response 
to frontal lobe activation among channels with 35 mm SDS induced by the Stroop task with 
maximum changes in ∆[oxCCO] varying from +0.015 µM (channel 21) to +0.073 µM 
(channel 23) in the presence of haemodynamic changes correlating to functional activation 
(increase in ∆[HbO2], decrease in ∆[HHb]). Figure 5(c) presents locations of the channels 
with significant response in ∆[HbO2], ∆[HHb] and ∆[oxCCO]. Out of 12 channels with SDS 
of 35 mm, 11 channels (92%) show significant increase in ∆[HbO2]; nine channels (75%) 
show significant decrease in ∆[HHb] and five channels (42%) show significant increase in 
∆[oxCCO]. Significant change in ∆[oxCCO] was only present in channels where there were 
significant changes in both ∆[HbO2], ∆[HHb]. Significant change in ∆[oxCCO] was not 
present in 30 mm or 20 mm SDS channels. However, significant changes in ∆[HbO2] were 
present in the 30 mm SDS (two out of three channels) and in 20 mm SDS (three out of four 
channels). Table 4 presents the mean response across nine subjects for ∆[HbO2], ∆[HHb] and 
∆[oxCCO] and the corresponding p value in channels with significant ∆[oxCCO] change as 
indicated in Fig. 5(c) (an extended table with the mean responses and p values for all 
channels is included as supplementary Table 1). 
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 Fig. 5. (a) Positions of 19 NIRS measurement channels on the adult forehead. Dark green, 
magenta and light blue circles indicate channels with SDS of 35 mm, 30 mm and 20 mm 
respectively. (b) Grand average concentration changes and standard error of mean of HbO2 
(red line), HHb (blue line) and 10 x (oxCCO) (green line) among 19 channels across nine 
subjects during the Stroop task. Plots with solid black borders are from channels with 35 mm 
separation, dashed black are from channels with 30 mm and dotted ones are from channels 
with 20 mm separation. The 60 s activation period is indicated by the shaded area. (c) 
Channels with significant increase in ∆[HbO2] (red squared border), decrease in ∆[HHb] (blue 
squared border) and increase in ∆[oxCCO] (green squared border). 
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Table 4. Mean response (Resp.) across nine subjects for each chromophore and the 
corresponding p value in channels with significant oxCCO changes. 
 Channel 7 Channel 8 Channel 9 Channel 13 Channel 14 
 Resp. 
(µM) p  
Resp. 
(µM) p  
Resp. 
(µM) p  
Resp. 
(µM) p  
Resp. 
(µM) p  
∆[HbO2] 0.135 0.026 0.176 0.018 0.185 0.022 0.163 0.033 0.193 0.026
∆[HHb] -0.059 0.007 -0.116 0.005 -0.110 0.014 -0.060 0.032 -0.093 0.020
∆[oxCCO] 0.024 0.005 0.033 0.009 0.024 0.036 0.028 0.027 0.029 0.035
3.4 Tissue oxygen saturation 
There is no observable TOI response during functional activation. Table 5 presents the mean 
TOI values during the experiment across six sites of measurement on the frontal lobe for each 
individual subject and the mean, standard deviation (SD), maximum and minimum values of 
TOI across nine subjects. 
Table 5. TOI (%) across 6 measurement sites of nine subjects 
Subject 
number 
Site 1 Site 2 Site 3 Site 4 Site 5 Site 6 Mean SD 
1 79 73 74 77 80 73 76 3 
2 81 73 70 72 76 N/A 74 4 
3 65 69 67 69 70 66 68 2 
4 89 74 73 78 80 87 80 6 
5 66 70 70 73 73 69 70 2 
6 78 74 75 73 77 76 76 2 
7 81 73 76 82 76 83 78 4 
8 61 69 69 71 72 75 69 4 
9 79 76 78 77 79 73 77 2 
Mean 76 72 72 75 76 75   
SD 9 2 4 4 4 6   
Min 61 69 67 69 70 66   
Max 89 76 78 82 80 87   
3.5 Multimodal data analysis 
There were significant differences (p<0.05) in the change in the mean blood pressure during 
functional activation induced by the Stroop task with the mean ± SD change of 2.7 ± 1.9 
mmHg. There was no significant difference in the end tidal carbon dioxide, arterial oxygen 
saturation, or scalp blood flow during the functional activation task. Regarding the change in 
heart rate, there was no significant change during the first 10 s of stimulation but there was a 
significant change during the last 10 s of stimulation compared to the baseline (p<0.05). 
Figure 6 shows grand average changes of systemic variables across subjects including a) 
mean blood pressure, b) heart rate, c) end-tidal CO2 and d) laser Doppler scalp blood flow. 
Variation in saturation is negligible. 
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 Fig. 6. Grand average changes in systemic variables (mean ± standard error) during frontal 
lobe functional activation induced by Stroop task. (a) Change in mean blood pressure 
(mmHg). (b) Change in heart rate (bpm). (c) Change in end tidal carbon dioxide (kPa). (d) 
Change in scalp blood flow in arbitrary Perfusion Unit. The shaded areas indicate the 60 s 
stimulation period. 
4. Discussion 
We have developed a multi-channel, multi-distance broadband near-infrared spectroscopy 
system with the capability of investigating the haemodynamic and oxCCO responses at 
multiple distances and locations across the prefrontal cortex. The system also has the 
capability of monitoring tissue oxygen saturation at multiple locations. Compared to 
previously described systems (as summarized in Table 1), our system can record ∆[HbO2], ∆[HHb] and ∆[oxCCO] from 24 simultaneously measured channels and TOI from six regions 
- by far the highest number of channels/regions for these measurements reported to date. We 
used the system to record functional activation-induced changes of ∆[HbO2], ∆[HHb] and ∆[oxCCO] in 19 channels in nine healthy adult volunteers across the prefrontal cortex and 
identified channels with significant changes in ∆[HbO2], ∆[HHb] and ∆[oxCCO]. 
Simultaneous with changes in these NIRS variables, we have also demonstrated that TOI 
differs slightly across different sites in the prefrontal cortex and across subjects. In addition, 
our system can be used in conjunction with systemic monitoring devices to acquire datasets 
including blood pressure changes, scalp blood flow changes, end tidal carbon dioxide, arterial 
oxygen saturation and heart rate. These datasets can provide a platform to investigate the 
spatial response of ∆[oxCCO] during functional activation in the presence of typical 
haemodynamic changes. Moreover, confounding effects of systemic physiology changes on 
NIRS functional activation data resulting in false positive or false negative interpretation of 
NIRS result [39] can also be investigated. 
System stability tests show that the dark noise of the system is randomly distributed 
across 108 wavelengths of measurements with a relatively low photon counts. Intensity 
measured over time shows an expected small variation due to system noise. 
The source interference test indicates that most of the measurement channels used for the 
calculation of concentration changes during the functional activation task have high SNRs; 
two channels did not and these were excluded from further analysis. The values of SNRs are 
relatively similar in both the phantom and the adult forehead; however, in general the SNRs 
from the adult forehead are more evenly distributed among measurement channels. This 
method of SNR calculation can be used in future experiments to characterise the behavior of 
each measurement channel before any experimental protocol. The differences observed in the 
light intensity measured by different detectors on the phantom having the same SDS may be 
due to a combinations of factors. These might include differences (i) in the diameter of 
detector fibre bundles (1.5 mm and 0.6 mm) and (ii) in the amount of light entering the 
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spectrographs due to small differences in slit width between spectrographs. However, these 
factors do not change over time. As a result, the attenuation measured by each channel can be 
reliably used to resolve concentration changes of chromophores. 
The maximum and minimum TOI values for six sites were within the range from 61% to 
89%. This range of TOI values agrees with the range of baseline TOIs from a large study 
performed by Al Rawi and colleagues to investigate the anatomical source of the calculated 
values of TOI by SRS technique in the adult heads using a NIRO 300 (Hamamatsu 
Photonics) during the clamping of internal and external carotid arteries [13]. This study 
provides evidence to support the hypothesis that TOI measurement reflects changes in 
cerebral tissue oxygenation. In our study there were small variations in TOI values across 
different sites within the same subject, and small variations of TOI values within the same 
site across different subjects. TOI does not have sufficient SNR to detect the oxygenation 
changes due to functional activation (this is an effect of the use of the slope to estimate the 
scaled absorption). The measurement of TOI across different brain regions may be used to 
assess absolute tissue oxygen saturation across these regions for clinical applications. 
Considering the NIRS result from this frontal lobe activation study, the group data shows 
changes of ∆[HbO2] and ∆[HHb] that are consistent with typical functional activation with 
increases in ∆[HbO2] and decreases in ∆[HHb] during the stimulation period. However, 
during the 60s stimulation period, ∆[HbO2] increases initially for around 10s then reaches a 
plateau before declining rapidly below the baseline. This finding agrees with a study using a 
similar Stroop protocol to investigate the changes in concentration of haemoglobin signals in 
different prefrontal cortex areas [40]. We have observed a small and insignificant difference 
in the magnitude of the ∆[HbO2] response between different SDS (see supplementary Table 
1). Short SDS measurements are confounded by the extracranial circulation and are largely 
affected by systemic changes and anxiety levels [41, 42]. Therefore, in certain circumstances 
large haemoglobin changes can be seen in short SDS channels. This makes it difficult to 
predict the magnitude of the response in the short channel and compares it to that from the 
longer SDS channels that sample both a portion of the extracranial and intracranial 
circulations. This is one of the rationales to investigate the possibility of using oxCCO signal 
for functional brain imaging to identify the specific location of the functional activation as 
oxCCO signal is less susceptible to changes in systemic variables and more brain specific 
[30]. Regarding the oxCCO response in this study, the depth dependency characteristic can 
be seen when comparing the response in paired channels sampling the same/similar tissue but 
at different depths. For example, comparing oxCCO response in the short (20 mm) and the 
long channels (35 mm), such as channels 11 and 9, or channel 12 and 10, as well as 18 and 
23, 17 and 15, a bigger maximum magnitude change in the channel with longer SDS can be 
observed. Such depth-dependency response of the oxCCO signal, reflecting its brain 
specificity characteristic, has been reported previously by Kolyva and colleagues [30]. 
Comparing the spatial variation of the oxCCO response to the haemoglobin responses 
(Fig. 5(c)), a significant change in Δ[oxCCO] was only seen in five channels with 35 mm 
SDS across the forehead where there were concurrent significant change in both ∆[HbO2] and 
∆[HHb]. In contrast, significant changes in Δ[HbO2] and Δ[HHb] were seen in most of the 35 
mm SDS channels (92% and 75% respectively), some of the 30 mm channels (67% and 0% 
respectively) and most of the 20 mm channels (100% and 75% respectively). The Stroop task 
is known to activate bilateral dorsolateral prefrontal cortices (DLPFC) [43, 44]. As we have 
explicitly stated in the paper, we consider activation as a significant increase in Δ[HbO2], a 
significant decrease in Δ[HHb] and a significant increase in Δ[oxCCO]. With our array 
positioned on the prefrontal cortex where source locations 2 and 3 were positioned at Fp2 and 
Fp1 of the 10/20 EEG electrode placement system, our results identify bilateral activation of 
the DLPFC. The haemoglobin signals are known to be confounded by extracranial 
contamination [39], while the oxCCO signal is more depth resolved [30, 45]. We can identify 
a more localised activation area when the oxCCO responses are considered in addition to 
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HbO2 and HHb. The increase in oxygen consumption is previously suggested to be more 
localised than the increase in blood flow [46] and our data might suggest that. Larger studies 
are required to differentiate regional variation in the magnitude of oxCCO response. 
There were also changes in some systemic physiological variables during the Stroop task. 
The significant change in blood pressure, although small in magnitude, may confound the 
NIRS results leading to false-positive or false-negative responses as described by Tachtsidis 
and Scholkmann [39]. 
To our knowledge, this is the first study demonstrating the difference in oxCCO response 
to functional activation across multiple areas of the frontal cortex that are distinct from the 
haemoglobin responses. Previously, the spatial distribution of oxCCO response to functional 
activation has been measured in the visual cortex using similar setup [47]; however, the 
acquisition time using that system was slow and the recordings of all measurement channels 
were not collected simultaneously. Using the multi-channel broadband NIRS system 
described in this paper, multi-channel measurements of changes in haemodynamics and 
metabolism as well as tissue oxygen saturation can be acquired simultaneously. This multi-
channel, multi-wavelength data can be used to reconstruct images of ∆[HbO2], ∆[HHb] and 
especially ∆[oxCCO] which may open up a new frontier to investigate cellular oxygen 
metabolism across multiple areas of the human cortex in different clinical scenarios. 
5. Conclusion 
We have developed a multi-channel, multi-distance broadband NIRS system to measure not 
only changes in haemodynamics (∆[HbO2] and ∆[HHb]), but also changes in cellular oxygen 
metabolism (∆[oxCCO]) and absolute tissue oxygen saturation (TOI) at multiple locations 
across the human adult prefrontal cortex. We have used the new system to collect functional 
NIRS data across the prefrontal cortex of nine healthy adult volunteers during a Stroop task 
and identified channels with significant change in Δ[HbO2], Δ[HHb] and Δ[oxCCO]. Multi-
channel, multi-distance NIRS datasets collected in conjunction with systemic data allow 
multimodal data analysis. This provides an unprecedented opportunity to understand and 
interpret the spatial response of NIRS variables in multiple locations, especially the NIRS-
derived oxCCO signal, during functional brain activation. 
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